Exchange: NASDAQ·Updated 07:30 PM EDT

AGMB AgomAb Therapeutics NV - ADR

$13.17
$0.67
(4.84%)
Today
Closed $13.17
$0.00
(0.00%)
After Hours
Mkt Cap$648.6M
Vol252,920.00

About AGMB

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.
56

Bullish Sentiment

How do you feel about AGMB?

Advertisement|Remove ads.